Notch signaling modulates Fgf23 expression through crosstalk with hypoxia and PTH pathways in osteogenic cells
Molecular and Cellular Endocrinology · 2025-12 · 610 · 112663
DOI: 10.1016/j.mce.2025.112663 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular and Cellular Endocrinology, 2025-12. Verfasst von Yoshihiro Tamamura und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy and Cell Biology, Institute of Biomedical Science, Tokushima University Graduate School, Tokushima, 770-8503, Japan; Oral Healt…. Hauptthemen laut MEDLINE: Fibroblast Growth Factors, Signal Transduction, Parathyroid Hormone, Osteogenesis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: JSPA, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Fibroblast growth factor 23 (Fgf23) is produced by bone and functions primarily as a phosphaturia hormone. We previously reported that overexpression of the Notch intracellular domain (NICD) in osteogenic cells enhances Fgf23 expression in association with osteomalacia in vivo. Here, we investigated the underlying mechanisms using osteogenic cell lines UMR-106 and IDG-SW3 cells. NICD overexpression increased Fgf23 levels in both cell types. Manipulating RBPJ-κ activity, either a dominant-negative or constitutively active form, revealed that Notch-mediated Fgf23 expression is dependent on RBPJ-κ. Treatment with iron chelator Desferrioxamine (DFO) upregulated Fgf23 expression, which was abolished by dominant-negative RBPJ-κ overexpression. This effect was partially attenuated by short hairpin RNA (shRNA) targeting hypoxia-inducible factor (HIF)-2α, but not HIF-1α. DFO treatment also increased expression of Notch1 protein, but not Notch2 and Nocth3, in parallel with upregulation of the Notch target mRNAs, Hes1 and Hey1. In addition, DFO elevated the expression of γ-secretase subunits, whereas a γ-secretase inhibitor suppressed DFO-induced increases in Notch1 and Fgf23 levels, suggesting that increased γ-secretase expression promotes Notch processing. Moreover, Notch signaling exerted an additive stimulatory effect on parathyroid hormone (PTH)-induced Fgf23 expression, at least in part through interaction with the protein kinase A (PKA) pathway. Co-immunoprecipitation assays revealed a physical interaction between NICD and CREB. Collectively, these findings demonstrate that Notch signaling regulates Fgf23 expression through crosstalk with hypoxic and PTH pathways, providing novel insights into Fgf23 regulation and identifying potential therapeutic targets for Fgf23-related disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anatomy and Cell Biology, Institute of Biomedical Science, Tokushima University Graduate School, Tokushima, 770-8503, Japan; Oral Health Science Center, Tokyo Dental College, Tokyo, 101-0061, Japan. Electr…
- Department of Anatomy and Cell Biology, Institute of Biomedical Science, Tokushima University Graduate School, Tokushima, 770-8503, Japan.
- Oral Health Science Center, Tokyo Dental College, Tokyo, 101-0061, Japan. Electronic address: akira@tdc.ac.jp.
Förderung
- JSPA
- Japan Society for the Promotion of Science
Zitieren
APA
Tamamura, Y., Terai, K., & Yamaguchi, A. (2025). Notch signaling modulates Fgf23 expression through crosstalk with hypoxia and PTH pathways in osteogenic cells. Molecular and Cellular Endocrinology, 610, 112663. https://doi.org/10.1016/j.mce.2025.112663
Vancouver
Tamamura Y, Terai K, Yamaguchi A. Notch signaling modulates Fgf23 expression through crosstalk with hypoxia and PTH pathways in osteogenic cells. Molecular and Cellular Endocrinology. 2025;610:112663. doi:10.1016/j.mce.2025.112663
BibTeX
@article{Tamamura2025,
author = {Tamamura, Yoshihiro and Terai, Kenta and Yamaguchi, Akira},
title = {Notch signaling modulates Fgf23 expression through crosstalk with hypoxia and PTH pathways in osteogenic cells},
journal = {Molecular and Cellular Endocrinology},
year = {2025},
volume = {610},
pages = {112663},
doi = {10.1016/j.mce.2025.112663}
}
EUVIMED